Cargando…

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals

The global Coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has affected more than eight million people. There is an urgent need to investigate how the adaptive immunity is established in COVID-19 patients. In this study, we profiled adaptive immune cells of PBMCs from recovered COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fan, Gan, Rui, Zhen, Ziqi, Hu, Xiaoli, Li, Xiang, Zhou, Fengxia, Liu, Ying, Chen, Chuangeng, Xie, Shuangyu, Zhang, Bailing, Wu, Xiaoke, Huang, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426596/ https://www.ncbi.nlm.nih.gov/pubmed/32796814 http://dx.doi.org/10.1038/s41392-020-00263-y

Ejemplares similares

Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
por: Zhang, Fan, et al.
Publicado: (2021)

DBSCAN-SWA: An Integrated Tool for Rapid Prophage Detection and Annotation
por: Gan, Rui, et al.
Publicado: (2022)

PhageTailFinder: A tool for phage tail module detection and annotation
por: Zhou, Fengxia, et al.
Publicado: (2023)

CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing
por: Zhou, Fengxia, et al.
Publicado: (2023)

The differential immune response in mild versus fatal SARS-CoV2 infection()
por: Suster, David, et al.
Publicado: (2022)

Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals
por: Pradenas, Edwards, et al.
Publicado: (2022)

Dispersion of SARS‐CoV‐2 in air surrounding COVID‐19‐infected individuals with mild symptoms
por: Gohli, Jostein, et al.
Publicado: (2022)

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases
por: Carsetti, Rita, et al.
Publicado: (2020)

Characteristic Temporary Loss of Taste and Olfactory Senses in SARS-CoV-2-positive-Individuals with Mild Symptoms
por: Schmithausen, Ricarda M., et al.
Publicado: (2020)

Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the ‘Common Cold’
por: Stefano, George B., et al.
Publicado: (2020)

Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection
por: Shi, Yong-Lin, et al.
Publicado: (2022)

Correction: Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection
Publicado: (2021)

Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection
por: Petersen, Marvin, et al.
Publicado: (2023)

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
por: Cervia, Carlo, et al.
Publicado: (2021)

SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patients
por: Chang, Ya-Chieh, et al.
Publicado: (2022)

PHISDetector: A Tool to Detect Diverse In Silico Phage–host Interaction Signals for Virome Studies
por: Zhou, Fengxia, et al.
Publicado: (2022)

Autoantibody production is enhanced after mild SARS-CoV-2 infection despite vaccination in individuals with and without long COVID
por: Visvabharathy, L, et al.
Publicado: (2023)

MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals
por: Castelli, Erick C., et al.
Publicado: (2021)

Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2
por: Zhang, Ya-Nan, et al.
Publicado: (2021)

The Humoral Immune Response To SARS-CoV-2 Infection And/or Immunization in Immunocompromised Versus Immunocompetent Individuals
por: Illes, Peter, et al.
Publicado: (2022)

Comparison of immune response to SARS-COV-2 vaccine in COVID-recovered versus non-infected Individuals
por: Mushtaq, Saadiya, et al.
Publicado: (2023)

Comparison of Manual versus Automated SARS-CoV-2 Rapid Antigen Testing in Asymptomatic Individuals
por: Harris, David T., et al.
Publicado: (2023)

Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19
por: Underwood, Alexander P., et al.
Publicado: (2021)

Neuroradiological Features of Mild and Severe SARS-CoV-2 Infection
por: Pan, Simon, et al.
Publicado: (2020)

Blood lactate in mild and moderate ARDS secondary to SARS COV 2
por: Pagano, A., et al.
Publicado: (2023)

Water-soluble polythiophene-based colorimetry for the quick and accurate detection of SARS-CoV-2 RNA
por: Su, Fengxia, et al.
Publicado: (2023)

Adaptive immunity to SARS-CoV-2
por: Altmann, Daniel M
Publicado: (2020)

The adaptation of SARS-CoV-2 to humans
por: Tosta, Eduardo
Publicado: (2022)

SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma
por: Chen, Li, et al.
Publicado: (2022)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

SARS-CoV-2 in immunocompromised individuals
por: DeWolf, Susan, et al.
Publicado: (2022)

Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course
por: Hoeggerl, Alexandra Domnica, et al.
Publicado: (2023)

Clinical and virological features of asymptomatic and mild symptomatic patients with SARS‐CoV‐2 Omicron infection at Shanghai Fangcang shelter hospital
por: Zhang, Lin, et al.
Publicado: (2023)

Different mutations in SARS-CoV-2 associate with severe and mild outcome
por: Nagy, Ádám, et al.
Publicado: (2021)

Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
por: Shen, Jiaying, et al.
Publicado: (2023)

Ongoing Global and Regional Adaptive Evolution of SARS-CoV-2
por: Rochman, Nash D., et al.
Publicado: (2021)

Ongoing global and regional adaptive evolution of SARS-CoV-2
por: Rochman, Nash D., et al.
Publicado: (2021)

Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis
por: Zhang, Junwei, et al.
Publicado: (2023)

Medical Consultations Option and Influencing Factors for SARS-CoV-2 Infected Individuals — Beijing Municipality, China, December 2022
por: Li, Mingyue, et al.
Publicado: (2023)

Predicting Risky Sexual Behavior Among College Students Through Machine Learning Approaches: Cross-sectional Analysis of Individual Data From 1264 Universities in 31 Provinces in China
por: Li, Xuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b6angdeqlqcal20srpne06kv44